For adults with sudden sensorineural hearing loss, with or without tinnitus, and with an onset within the past 14 days, does the application of hyperbaric oxygen therapy, in addition to the standard therapy of oral steriods, result in an improvement in hearing, tinnitus or quality of life?

Michael Bennett0 个研究点目标入组 225 人开始时间: 2009年7月27日最近更新: 2020年1月13日

试验速览

暂无简介。

•All adult patients (>18 yrs) presenting with idiopathic sudden sensorineural hearing loss (ISSHL), with or without tinnitus and where the first hyperbaric session can be administered within 14 days of the onset of symptoms. Diagnosis will exclude other causes of sudden hearing loss historically (e.g. Menieur’s disease, barotrauma, noise-induced hearing loss, ototoxic drugs) and by a magnetic resonance image (MRI) of the affected side to exclude an acoustic neuroma or other tumour.

•Patient refusal (HBOT will not be offered to those who refuse to participate),
•Contraindications to HBOT including inability to equalise the middle ear or respiratory sinuses, claustrophobia, pneumothorax, previous bleomycin administration or severe respiratory disease with carbon dioxide retention, presence of hearing decrement (documented) for greater than two weeks.

发起方

Michael Bennett